SGRY — Surgery Partners Income Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapContrarian

Annual income statement for Surgery Partners, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	2,225	2,539	2,743	3,114	3,309
Cost of Revenue
Gross Profit	582	657	732	835	853
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	1,923	2,194	2,415	2,766	2,919
Operating Profit	302	345	328	349	390
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	81.2	110	135	147	117
Provision for Income Taxes
Net Income After Taxes	70.7	87	135	12.5	98.9
Minority Interest
Net Income Before Extraordinary Items
Net Income	-70.9	-54.6	-11.9	-168	-77.9
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-81.2	-54.6	-11.9	-168	-77.9
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-0.822	-0.434	0.519	-0.529	0.283